Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
CN¥ 45.46
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Shanghai Model Organisms Center, Inc. engages in the research and development of genetically modified animal models in China. It develops tool, disease, fluorescent reporter, humanized, and immunodeficient mice; humanized, immunodeficient, disease, tool, and fluorescent reporter rats; and fluorescent-labeled, primary, and humanized cells. It also provides model customization, living body model, breeding, phenotypic analysis, and drug...
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITDA, overvalue
Data is available to registered users only
Buy
Sell